CYP19A1 and disease of the tendon: Barring the relationship between fluoroquinolone exposure and tendon disorder occurrence, exposure to statins, aromatase inhibitors, and glucocorticoids is also reportedly related to the occurrence of tendon disorders (Marie et al., 2008; Laroche et al., 2017; Mitsimponas et al., 2018; Wise et al., 2012; van der Linden et al., 2002).